External events

On Friday 25th November our president Lynne van Poelgeest will participate in a workshop callled “Commitment to Collaboration in Continence Care”. Commitment to Collaboration in Continence Care is a day-long workshop held during the annual conference of the Sociedad Iberoamericana de Neurourología y Uroginecología (SINUG) in Madrid  (Madrid, 25 November 2022). The workshop will include […]

The President of WFIPP, Mary Lynne van Poelgeest, will be participating in this Summit in her role as Co-Chair of the EU Health Coalition. The event will build on the stark lessons learned from COVID-19 and discuss how to go beyond the status-quo in health, seizing opportunities to make positive changes. It will ask what […]

EUREGHA’S 10th ANNIVERSARY – SPECIAL ISSUE  With great pleasure the EUREGHA secretariat announces the launch of EUREGHA’s 10th anniversary campaign. Completing our first decade in the EU health bubble is certainly a milestone worthy of celebration! 10 Years of EUREGHA – moving towards a new approach to achieve innovative, sustainable, future-proof health systems delivering better care for all. 10 fruitful […]

Value-based procurement: MedTech’s VBP event (15th December 2022 in Brussels – interested members please reach out! MedTech Europe has been partnering with EHPPA (European procurement association) and BCG on the topic of value-based procurement to drive forward and support a value-based healthcare approach in Europe. One of the key activities they organise on a regular […]

Our president Lynne van Poelgeest will be one of the speakers at the World Drug Safety Congress Europe 2022 in Amsterdam

The Czech National Association of Patient Organizations (NAPO) is taking the opportunity of the Czech presidency of the Council of the EU and organizes an international conference in Prague titled “Involving Patient Organizations in Health Policy Decision-Making”. Representatives of European patient organizations, Czech public health institutions and other stakeholders will explore the future role of patient organizations […]

March is coming fast! Start making preparations for EAU23 and see what the Patient Office has to offer. The annual congress is an opportunity to network, present your research, make yourself heard, learn, and patient advocates can register for free. Continue below for all you need to know for your EAU23 experience. Free Registration for Patient Advocates […]

The EAU Section of Genito-Urinary Reconstructive Surgeons (ESGURS) is holding the 12th edition of its Section Meeting in Madrid, Spain from 20-21 October, 2022. The meeting will be held in conjunction with the ESU-ESAU-ESGURS Masterclass on Erectile Restoration and Peyronie’s disease, held on 19-20 October. (For more details, see below!)

On the launch of the “incontinence thematic Innovation Ecosystem”.

RNA therapeutics are a new class of medicines that have a broad applicability targeting disease relevant proteins. Proteins are large and complex molecules that play a critical role in the body’s capacity to be healthy. Currently, most approved drugs are small molecules and protein biologics, which can only target a very limited number of proteins or genes. Our RNA-based therapeutics can be used to selectively trigger protein overexpression or downregulation, for single or multiple protein targets with one RNA construct. This uncovers new therapeutic possibilities for previously undruggable targets.

THURSDAY 23rd JUNE 2022 – 15.30-16.30 HRS (CET) Jiri Vermeulen, Wilfried Woesthuis, Minze Health and Prof. Stefan De Wachter, urologist at the University Hospital in Antwerp The automated bladder diary is a product intended to increase the patient compliance, usability and reliability of bladder diaries. Bladder diaries are an important tool ideally used throughout the […]

Novuqare works together with healthcare professionals and patients on research and projects to initiate innovations and to develop clinically relevant healthcare solutions. Since their founding in 2011 they have developed long-term collaborations with several renowned healthcare partners. Their mission is to improve the care and health of patients by developing unique, innovative, medical-technological applications and services.

Tilla Care’s Cap Female Kit, including all the accessories (extension tube, lubricant gel, securement device and alcohol pads) has been developed by TillaCare Ltd., Israel. The UriCap is intended to be used as an external urine collection system for incontinent elderly women and can in many cases replace incontinence pads and invasive catheters.

Subject: the role of Sacral Neuromodulation (SNM) in the management of pelvic floor dysfunction, whereby Dr. Grilo will explain what Sacral Neuromodulation is, the indications and the results. Laura Thomas will talk about patient expectations, patient education and patient follow-up. Finally, a patient?? will say something about his/her experience (from diagnosis to SNM treatment).

Muvon Therapeutics have developed a highly innovative technology offering patients a minimally invasive, low-risk procedure (according to phase I data) in an outpatient setting. Potentially this procedure could prove a life changer and be long-lasting.